Preferred Label : Triple-Class Refractory Multiple Myeloma;

NCIt synonyms : Triple-Class Refractory Plasma Cell Myeloma;

NCIt definition : Multiple myeloma that is resistant to three classes of therapeutic agents, including proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies.;

Neoplastic status : Malignant;

NCI Metathesaurus CUI : CL1647794;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3303102/fr/abecma-idecabtagene-vicleucel-myelome-multiple
https://has-sante.fr/jcms/p_3303143/fr/decision-n-2021-0311/dc/sem-du-2-decembre-2021-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-abecma-idecabtagene-vicleucel
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
Idecabtagene Vicleucel
Idecabtagene Vicleucel
Receptors, Chimeric Antigen
immunotherapy, adoptive
adult
recurrence
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
infusions, intravenous
Triple-Class Refractory Multiple Myeloma
idecabtagene vicleucel
idecabtagene vicleucel
evaluation of the transparency committee
multiple myeloma

---
Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.